4.7 Article

Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma

Journal

CANCER
Volume 119, Issue 11, Pages 2005-2011

Publisher

WILEY
DOI: 10.1002/cncr.28015

Keywords

oropharyngeal carcinoma; head and neck squamous cell carcinoma; p16; human papillomavirus; alcohol consumption; Japan

Categories

Funding

  1. Grants-in-Aid for Scientific Research [24791750] Funding Source: KAKEN

Ask authors/readers for more resources

BACKGROUND The prevalence and prognostic value of human papillomavirus-related oropharyngeal squamous cell carcinoma (OPSCC) in Japan has not been evaluated. METHODS Over a 12-year period, the authors used immunohistochemistry to evaluate the expression of p16 (a cyclin-dependent kinase inhibitor and tumor suppressor) in samples from 173 patients with OPSCC at a single institution and to determine its prevalence and influence on disease prognosis. RESULTS The prevalence of p16-positive OPSCC was 33.7% in tonsillar carcinoma, 28.6% in tongue base carcinoma, 0% in posterior wall carcinoma, and 18.8% in soft palate carcinoma. The prevalence of p16-positive OPSCC tumors increased from 15.2% during 2000 to 2003 up to 33.3% during 2008 to 2011; during the same periods, among nonsmokers, the prevalence of p16-positive OPSCC tumors increased from 21.2% to 27.8%; and, among nondrinkers, prevalence increased from 6.1% to 25%. Multivariate analysis identified p16 expression and alcohol consumption as significant, independent prognostic markers of OPSCC. CONCLUSIONS The current results suggest that the incidence of human papillomavirus-related OPSCC in Japan is increasing and indicate that p16 expression and alcohol consumption may be significant prognostic markers of survival for patients with OPSCC in Japan. Cancer 2013;119:20052011. (c) 2013 American Cancer Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant

Chao Liu, Theresa Guo, Guorong Xu, Akihiro Sakai, Shuling Ren, Takahito Fukusumi, Mizuo Ando, Sayed Sadat, Yuki Saito, Zubair Khan, Kathleen M. Fisch, Joseph Califano

CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers

Mizuo Ando, Yuki Saito, Guorong Xu, Nam Q. Bui, Kate Medetgul-Ernar, Minya Pu, Kathleen Fisch, Shuling Ren, Akihiro Sakai, Takahito Fukusumi, Chao Liu, Sunny Haft, John Pang, Adam Mark, Daria A. Gaykalova, Theresa Guo, Alexander Favorov, Srinivasan Yegnasubramanian, Elana J. Fertig, Patrick Ha, Pablo Tamayo, Tatsuya Yamasoba, Trey Ideker, Karen Messer, Joseph A. Califano

NATURE COMMUNICATIONS (2019)

Article Oncology

A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma

Chao Liu, Theresa Guo, Akihiro Sakai, Shuling Ren, Takahito Fukusumi, Mizuo Ando, Sayed Sadat, Yuki Saito, Joseph A. Califano

CANCER (2020)

Article Otorhinolaryngology

Spinal solitary fibrous tumor of the neck: Next-generation sequencing-based analysis of genomic aberrations

Mizuo Ando, Hiroshi Kobayashi, Aya Shinozaki-Ushiku, Hirotaka Chikuda, Yoshitaka Matsubayashi, Masafumi Yoshida, Yuki Saito, Shinji Kohsaka, Katsutoshi Oda, Kiyoshi Miyagawa, Hiroyuki Aburatani, Hiroyuki Mano, Tatsuya Yamasoba

AURIS NASUS LARYNX (2020)

Article Oncology

Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation

Chao Liu, Sayed H. Sadat, Koji Ebisumoto, Akihiro Sakai, Bharat A. Panuganti, Shuling Ren, Yusuke Goto, Sunny Haft, Takahito Fukusumi, Mizuo Ando, Yuki Saito, Theresa Guo, Pablo Tamayo, Huwate Yeerna, William Kim, Jacqueline Hubbard, Andrew B. Sharabi, J. Silvio Gutkind, Joseph A. Califano

CLINICAL CANCER RESEARCH (2020)

Article Otorhinolaryngology

Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma

Yuki Saito, Alexander Favorov, Michael Forman, Shuling Ren, Akihiro Sakai, Takahito Fukusumi, Chao Liu, Sayed Sadat, Mizuo Ando, Guorong Xu, Zubair Khan, John Pang, Alex Valsamakis, Kathleen M. Fisch, Joseph A. Califano

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)

Article Otorhinolaryngology

Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer

Sarek Shen, Yuki Saito, Shuling Ren, Chao Liu, Theresa Guo, Jesse Qualliotine, Zubair Khan, Sayed Sadat, Joseph A. Califano

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2020)

Article Multidisciplinary Sciences

Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing

Akihiro Sakai, Mizuo Ando, Takahito Fukusumi, Shuling Ren, Chao Liu, Jesse Qualliotine, Sunny Haft, Sayed Sadat, Yuki Saito, Theresa W. Guo, Guorong Xu, Roman Sasik, Kathleen M. Fisch, J. Silvio Gutkind, Elana J. Fertig, Alfredo A. Molinolo, Joseph A. Califano

PLOS ONE (2020)

Article Oncology

Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national head and neck cancer registry of Japan

Yuki Saito, Ryuichi Hayashi, Yoshiyuki Iida, Takatsugu Mizumachi, Takashi Fujii, Fumihiko Matsumoto, Takeshi Beppu, Masafumi Yoshida, Hirotaka Shinomiya, Ryosuke Kamiyama, Mutsukazu Kitano, Kazuhiko Yokoshima, Yasushi Fujimoto, Takanori Hama, Taku Yamashita, Kenji Okami, Kouki Miura, Takuo Fujisawa, Daisuke Sano, Hisayuki Kato, Shujiro Minami, Masashi Sugasawa, Muneyuki Masuda, Ichiro Ota, Shigemichi Iwae, Ryo Kawata, Nobuya Monden, Takayuki Imai, Takahiro Asakage, Masafumi Okada, Takanori Yoshikawa, Kensuke Tanioka, Megumi Kitayama, Mariko Doi, Satoshi Fujii, Masato Fujii, Nobuhiko Oridate, Munenaga Nakamizo, Seiichi Yoshimoto, Akihiro Homma, Ken-ichi Nibu, Katsunari Yane

CANCER (2020)

Article Oncology

Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma

Takahito Fukusumi, Theresa W. Guo, Shuling Ren, Sunny Haft, Chao Liu, Akihiro Sakai, Mizuo Ando, Yuki Saito, Sayed Sadat, Joseph A. Califano

Summary: The study found that in head and neck squamous cell carcinoma, HEY1 promotes EMT by upregulating SOX2 expression and forming a positive reciprocal feedback loop. HEY1 also regulates NOTCH4 expression, enhancing the specific upregulation of this pathway.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Article Multidisciplinary Sciences

Usefulness of circulating tumor DNA by targeting human papilloma virus-derived sequences as a biomarker in p16-positive oropharyngeal cancer

Ken Akashi, Toshihiko Sakai, Osamu Fukuoka, Yuki Saito, Masafumi Yoshida, Mizuo Ando, Takeshi Ito, Yoshinori Murakami, Tatsuya Yamasoba

Summary: Early detection of recurrence in head and neck cancer is crucial. We validated the usefulness of HPV-derived ctDNA as a biomarker for predicting the recurrence of p16-positive oropharyngeal cancer, providing a potential tool for monitoring disease progression.

SCIENTIFIC REPORTS (2022)

Review Oncology

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck

Susumu Okano, Akihiro Homma, Naomi Kiyota, Makoto Tahara, Nobuhiro Hanai, Takahiro Asakage, Kazuto Matsuura, Takenori Ogawa, Yuki Saito, Daisuke Sano, Takeshi Kodaira, Atsushi Motegi, Koichi Yasuda, Shunji Takahashi, Kaoru Tanaka, Takuma Onoe, Tomoya Yokota, Yoshinori Imamura, Yosuke Ariizumi, Tetsuo Akimoto, Ryuichi Hayashi

Summary: Induction chemotherapy is a treatment option for head and neck squamous cell carcinoma, with the current standard regimen being docetaxel, cisplatin and 5-FU. Careful consideration should be given to factors such as toxicity, cost, and treatment duration when choosing this therapy, and there is still no consensus on the best treatment option after induction chemotherapy.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

A retrospective analysis of radiotherapy in the treatment of external auditory canal carcinoma

Atsuto Katano, Ryousuke Takenaka, Hideomi Yamashita, Mizuo Ando, Masafumi Yoshida, Yuki Saito, Takahiro Asakage, Osamu Abe, Keiichi Nakagawa

Summary: This study retrospectively evaluated the clinical outcomes of 34 patients with external auditory canal carcinoma treated with EBRT, showing slightly different 5-year overall survival rates and progression-free survival rates, with some patients experiencing disease relapse after treatment.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

Review Oncology

Immunotherapy for squamous cell carcinoma of the head and neck

Tomoya Yokota, Akihiro Homma, Naomi Kiyota, Makoto Tahara, Nobuhiro Hanai, Takahiro Asakage, Kazuto Matsuura, Takenori Ogawa, Yuki Saito, Daisuke Sano, Takeshi Kodaira, Atsushi Motegi, Koichi Yasuda, Shunji Takahashi, Kaoru Tanaka, Takuma Onoe, Susumu Okano, Yoshinori Imamura, Yosuke Ariizumi, Ryuichi Hayashi

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma

Go Omura, Mizuo Ando, Yasuhiro Ebihara, Yuki Saito, Kenya Kobayashi, Osamu Fukuoka, Ken Akashi, Masafumi Yoshida, Takahiro Asakage, Tatsuya Yamasoba

BMC CANCER (2017)

No Data Available